Published • loading... • Updated
Can herpes fight cancer? Plus, Trump’s vaccine order, a drug-resistant fungus and the mRNA flu shot
The treatment, called Tudriqev, uses a modified herpes virus to attack tumor cells, and Moderna’s new flu shot was 27% more effective in trials.
Summary by Straight Arrow News
4 Articles
4 Articles
Stronger, faster, better: the new mRNA flu vaccine
The Food and Drug Administration (FDA) has approved Moderna’s mRNA flu vaccine, mFLUSIVA. The approval comes despite growing vaccine skepticism, especially toward mRNA vaccines following Covid-19. But research shows that this new vaccine can produce a stronger immune response and be produced more quickly than the traditional flu vaccine.How does the mRNA vaccine differ from the traditional shot?The approval of mFLUSIVA “demonstrates the continue…
·Bath, United Kingdom
Read Full Article
After delays, the US FDA approved the first mRNA flu vaccine • Moderna's mFlusiva vaccine is intended for people over the age of 50 • Faster production will allow for a much better response to new mutations of the flu virus
Coverage Details
Total News Sources4
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
